We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Reliability of Serum Metabolite Concentrations over a 4-Month Period Using a Targeted Metabolomic Approach

Researchers have investigated the between- and within-person variation of the concentrations of 163 serum metabolites over a period of 4 months to evaluate the metabolite reliability expressed by the intraclass-correlation coefficient.
News

Absolute Quantification of Microbial Proteomes at Different States by Directed Mass Spectrometry

This paper details how researchers have performed the first study that describes the absolute quantitative behaviour of any proteome over multiple states.
News

MBio Diagnostics, Inc. Wins NIH Award for Flu Test Development

MBio Diagnostics, Inc. announces it has received an award from the US National Institutes of Health to detect disease-causing respiratory pathogens in humans.
News

New European Lab Automation Event Saw Outstanding Success

With 1523 attendees and 151 exhibitors and media partners, feedback from European Lab Automation was overwhelmingly positive.
News

VacChina 2011- The Largest China’s Vaccine Meeting

The meeting welcomes world class biotechs and pharmas to discuss the opportunities of development of novel vaccine R&D and manufacturing technologies in China.
News

Medgenics Signs Exclusive License Agreement for Key Variants of Factor VIII

Company signed an exclusive license with Regents of the University of Michigan of patent rights relating to certain uses of variants of clotting Factor VIII developed by Professor Randall Kaufman.
News

Medivir to Acquire BioPhausia

Strategic and complementary acquisition, significantly strengthening Medivir’s commercial capabilities in the Nordic Market.
News

Advion BioServices First to Offer SISCAPA Assay Services for Biomarker Assays

The SISCAPA assays are mass spectrometry-based, and will be conducted in Advion’s LC/MS laboratory.
News

Oncolytics Biotech® Inc. Announces Second Quarter 2011 Results

Company announces financial results and operational highlights for the quarter ended June 30, 2011.
News

PII Expands Drug Formulation and Manufacturing Capabilities With Hot Melt Extrusion Technology

Pii to carry out feasibility studies, using few grams of active pharmaceutical ingredient, to pilot scale cGMP productions for Phase I and II clinical trials using HME.
Advertisement